TNP-470 and Hepatic Artery Ligation in Liver Tumor Treatment
Author Information
Author(s): T Mugitani, H Taniguchi, A Takada, A Yamaguchi, M Masuyama, M Hoshima, T Takahashi
Primary Institution: First Department of Surgery, Kyoto Prefectural University of Medicine
Hypothesis
Can TNP-470 enhance the anti-tumor effect of hepatic artery ligation in liver tumors?
Conclusion
TNP-470 combined with hepatic artery ligation significantly reduced tumor volumes compared to either treatment alone.
Supporting Evidence
- Tumor volumes in the ligation + TNP group were significantly smaller than in the ligation group and the TNP group on day 14 after treatment.
- TNP-470 inhibited the proliferation of new microvascular channels that develop after hepatic artery ligation.
- The anti-tumor effect of hepatic artery ligation was temporary due to the tumor's ability to derive blood supply from collaterals.
Takeaway
This study tested a drug called TNP-470 to see if it helps shrink liver tumors when combined with a surgery that cuts off blood supply to the tumor.
Methodology
Rabbits with VX2 tumors were treated with hepatic artery ligation, TNP-470 infusion, or both, and tumor sizes were measured over 14 days.
Limitations
Tumor volume did not decrease from pretreatment size in any group, indicating limitations in treatment effectiveness.
Participant Demographics
Japanese white rabbits (2.5-3.0 kg)
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website